ONTX Onconova Therapeutics Inc

Onconova Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in discovering and developing novel small molecule drug candidates to treat cancer. The Company has three clinical-stage product candidates and six preclinical programs.

$0.97  -0.06 (-6.14%)
As of 09/22/2022 16:00:01 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  07/25/2013
Outstanding shares:  20,895,563
Average volume:  67,267
Market cap:   $19,808,994
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Valuation   (See tab for details)
PE ratio:   -1.30
PB ratio:   0.48
PS ratio:   176.87
Return on equity:   -36.82%
Net income %:   -13,901.79%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy